Vermont 2026 Biennium Status: In Committee Bipartisan · 2 R · 1 D cosponsors

H.676 — An act relating to maintaining patient access to animal-derived thyroid medications

Last action — Read first time and referred to the Committee on Health Care

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced January 14, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 36% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 3 sponsors

    1 primary, 2 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (2 R · 1 D) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

An act relating to maintaining patient access to animal-derived thyroid medications

Bill Text

We don't have the full text on file for this bill yet.

Read H.676 on the official Vermont source →

Action History

  1. Read first time and referred to the Committee on Health Care

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 187 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (187)

187 members have not signed on to this bill.

Show all 187 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does H.676 do?
An act relating to maintaining patient access to animal-derived thyroid medications
Who sponsors H.676?
H.676 is sponsored by Gregory "Greg" Burtt (Republican), David "Dave" Bosch (Republican), and Robert J Hooper (Democrat).
What is the current status of H.676?
This bill is in committee in the House. Introduced January 14, 2026. It must pass committee before a floor vote.
Where can I track H.676?
Track H.676 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on H.676

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of H.676

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →